These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 20573382)

  • 1. Higher body mass index is associated with lower risk of prostate cancer detection via multi (≥ 12)-core prostate biopsy in Korean men.
    Lee SE; Hong SK; Park HZ; Chang JS; Yoon CY; Byun SS; Abdullajanov M
    Urology; 2010 Nov; 76(5):1063-6. PubMed ID: 20573382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)-core prostate biopsy.
    Hong SK; Oh JJ; Byun SS; Hwang SI; Lee HJ; Choe G; Lee SE
    Prostate; 2012 Jan; 72(1):51-7. PubMed ID: 21520162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation.
    Pepe P; Aragona F
    Urology; 2007 Dec; 70(6):1131-5. PubMed ID: 18158033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship of body mass index with cancer detection in prostate biopsy].
    Chen HX; Wang X; Zhang G; Fang ZL; Ding ZS; Liu NB
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2820-2. PubMed ID: 21162790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical impact of body mass index on prostate biopsy in patients with intermediate PSA levels].
    Sekita N; Suzuki H; Kamijima S; Chini K; Fujimura M; Mikami K
    Hinyokika Kiyo; 2008 Jul; 54(7):479-83. PubMed ID: 18697492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection rate of prostate cancer on biopsy according to serum prostate-specific antigen in Korean men: a multicenter study.
    Yang WJ; Lee DH; Chung BH; Cho JS; Choi YD; Kim SJ; Cho IR; Kim HS; Kim CI; Hong SJ;
    Urology; 2006 Feb; 67(2):333-6. PubMed ID: 16461083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of peripheral biopsies in maximising early prostate cancer detection in 8-, 10- or 12-core biopsy regimens.
    Philip J; Ragavan N; Desouza J; Foster CS; Javlé P
    BJU Int; 2004 Jun; 93(9):1218-20. PubMed ID: 15180609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection rate of prostate cancer according to prostate-specific antigen and digital rectal examination in Korean men: a nationwide multicenter study.
    Seo HK; Chung MK; Ryu SB; Lee KH;
    Urology; 2007 Dec; 70(6):1109-12. PubMed ID: 18158028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index as a predictor of prostate cancer: development versus detection on biopsy.
    Freedland SJ; Terris MK; Platz EA; Presti JC
    Urology; 2005 Jul; 66(1):108-13. PubMed ID: 15992911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy.
    Yokomizo Y; Miyoshi Y; Nakaigawa N; Makiyama K; Ogawa T; Yao M; Kubota Y; Uemura H
    Urol Int; 2009; 82(3):280-5. PubMed ID: 19440014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of increased number of biopsies on the nature of prostate cancer identified.
    Meng MV; Elkin EP; DuChane J; Carroll PR
    J Urol; 2006 Jul; 176(1):63-8; discussion 69. PubMed ID: 16753368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.
    Eskicorapci SY; Guliyev F; Akdogan B; Dogan HS; Ergen A; Ozen H
    J Urol; 2005 May; 173(5):1536-40. PubMed ID: 15821481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate specific antigen mass ratio potential as a prostate cancer screening tool.
    Choi HC; Park JH; Cho BL; Son KY; Kwon HT
    J Urol; 2010 Aug; 184(2):488-93. PubMed ID: 20620404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
    Lane BR; Zippe CD; Abouassaly R; Schoenfield L; Magi-Galluzzi C; Jones JS
    J Urol; 2008 May; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of lateral biopsy specimens during transrectal ultrasound-guided prostate biopsies in Japanese men.
    Shigemura K; Arakawa S; Yamanaka K; Kataoka N; Yuien K; Fujisawa M
    Int J Urol; 2007 Oct; 14(10):935-8. PubMed ID: 17880293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index influences prostate-specific antigen in men younger than 60 years of age.
    Kim YJ; Han BK; Hong SK; Byun SS; Kim WJ; Lee SE
    Int J Urol; 2007 Nov; 14(11):1009-12. PubMed ID: 17956528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Four regions 12-core systemic prostate biopsy for diagnosis of prostate cancer].
    Wu R; Zheng K; Li X; Zhong W
    Zhonghua Nan Ke Xue; 2004 Jul; 10(7):493-5. PubMed ID: 15354516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.